Principal Investigator

1. Multi-Module analysis approach for pathway-Interacting deferentially expressed genes in cancer genomics data. (113-2221-E-037 -007 -MY2) 2024.08-2026.07.

2. Constructing an artificial intelligence platform for estimating immunomodulatory drug response based on a smart grid architecture model. (KMU-DK(B)114002-1) 2025.01-2025.12.

1. Cheng-Hong Yang†, Sin-Hua Moi†, Li-Yeh Chuang*, Yu-Da Lin* (2025, Feb). An Information Fusion System-Driven Deep Neural Networks with Application to Cancer Mortality Risk Estimate. IEEE Transactions on Neural Networks and Learning Systems, 36(2), 2905-2916.  

2. Wei-Chang Lee, Sin-Hua Moi, Sheau-Fang Yang, Ho-Hsing Tseng, Yu-Peng Liu* (2025, Jan). Downregulation of AATK enhances susceptibility to ferroptosis by promoting endosome recycling in gefitinib‐resistant lung cancer cells. The Journal of Pathology. 265(4), 422-436.

1. Wei-Feng Li, Sin-Hua Moi, Yueh-Wei Liu, Chih-Che Lin, Chee-Chien Yong, Chih-Chi Wang*, Yi-Hao Yen*, Chih-Yun Lin. (2024, Nov). A preoperative model to predict overall survival in patients with hepatoma undergoing resection. The American Journal of Surgery. 237, 115778.

2. Shih-Feng Cho, Tsung-Jang Yeh, Hui-Ching Wang, Jeng-Shiun Du, Yuh-Ching Gau, Yu-Yin Lin, Tzer-Ming Chuang, Yi-Chang Liu, Hui-Hua Hsiao, Sin-Hua Moi* (2024, Mar). Prognostic mutation signature would serve as a potential prognostic predictor in patients with diffuse large B-cell lymphoma. Scientific Reports, 14(1), 6161.

3. Chih-Chiang Hung, Sin-Hua Moi, Hsin-I Huang, Tzu-Hung Hsiao*, Chi-Cheng Huang* (2024, Mar). Polygenic risk score-based prediction of breast cancer risk in Taiwanese women with dense breast using a retrospective cohort study. Scientific Reports, 14(1), 6324.

4. Chao-Ming Hung, Sin-Hua Moi* (2024, Sep). Prognostic effects of ABCB1 and TMEM14B expression in triple-negative breast cancer. 2024 Taipei International Breast Cancer Symposium (TIBCS 2024), Taipei, Taiwan. 

5. Sin-Hua Moi*, Yu-Da Lin, Yi-Ling Chen, Chao-Ming Hung, Shin-Jiun Tsai, Wei-Hong Cheng. (2024, Jul). Driver Gene Expression Clustering Model for Prognostic Risk Estimation Using Cancer Genomic Data. 2024 IEEE 48th Annual Computers, Software, and Applications Conference (COMPSAC), pp. 1576-1577. 

6. Chih-Yean Lum, Chih-Chiang Hung, Chi-Cheng Huang, Tzu-Hung Hsiao, Sin-Hua Moi (2024, May). Abstract PO5-08-10: Breast cancer risk prediction performance of polygenic risk score in Taiwanese female with dense breast: A nested case-control study. Cancer Research 84, no. 9_Supplement (2024): PO5-08.

1. Heng-Jui Chang, Sin-Hua Moi, Yu-Jiun Chan, Tzuo-Yun Lan* (2023, Dec). A non-socially-sensitive predictive model of prostate cancer for Asian males with benign prostatic hyperplasia: A multi-site cross-sectional case-control study. PLoS One, 18(12): e0295608.

2. Wei-Lun Huang, Chi-Wen Luo, Huei-Shan Lin, Chao-Ming Hung, Fang-Ming Chen, Sin-Hua Moi*, Mei-Ren Pan* (2023, Nov). SUV39H1 Expression as a Guideline for Omitting Radiotherapy in Lymph Node-positive Triple-negative Breast Cancer Patients. Cancer Genomics & Proteomics 20 (6), 582-591.

3. Wei-Feng Li, Sin-Hua Moi, Yueh-Wei Liu, Chee-Chien Yong, Chih-Chi Wang, Yi-Hao Yen*, Chih-Yun Lin* (2023, Oct). Using the hazard function to evaluate hepatocellular carcinoma recurrence risk after curative resection. Updates in Surgery, 1-9.

4. Pai-Wei Su, Emirlyn Cheng Yang, Sin-Hua Moi, Cheng-Hong Yang*, Li-Yeh Chuang* (2023, Aug). Prevalence of Carbapenem Resistance Genes among Acinetobacter baumannii Isolated from a Teaching Hospital in Taiwan. Antibiotics, 12 (9), 1357.

5. Shih-Ming Hsiao, Mei-Chuan Kuo, Pei-Ni Hsiao, Sin-Hua Moi, Yi-Wen Chiu, Shu-Li Wang, Tzu-Hui Chen, Lan-Fang Kung, Shang-Jyh Hwang, Chia-Lun Lee* (2023, Aug). Shared decision-making for renal replacement treatment and illness perception in patients with advanced chronic kidney disease. BMC Medical Informatics and Decision Making 23 (1), 159.

6. Hui-Ching Wang, Sin-Hua Moi, Leong-Perng Chan, Chun-Chieh Wu, Jeng-Shiun Du, Pei-Lin Liu, Meng-Chun Chou, Che-Wei Wu, Chih-Jen Huang, Hui-Hua Hsiao, Mei-Ren Pan*, Li-Tzong Chen* (2023, May). The role of the genomic mutation signature and tumor mutation burden on relapse risk prediction in head and neck squamous cell carcinoma after concurrent chemoradiotherapy. Experimental & Molecular Medicine, 1-13.

7. Sin-Hua Moi, Huei-Ju Lin, Huei-Lan Lee, Dong-Hua Wang, Chao-Ming Hung* (2023, Sep). Mutation profiles of TMEM14B and co-occurrence of TP53 mutation in triple-negative breast cancer. 2023 Taipei International Breast Cancer Symposium (TIBCS 2023), Taipei, Taiwan.

8. Sin-Hua Moi, Yu-Da Lin* (2023, Jul). A deep learning weighting model to identify mortality associated missense variants using cancer genomic data. The 45th Annual International Conferenceof the IEEE Engineering in Medicine and Biology Society (EMBC 23), Sydney, Australia.